Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy

Tobacco Control

Volumn 24, Issue 2, 2015, Pages 182-189

  Peeters, Silvy ^a   Gilmore, Anna B ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; DOCUMENTATION; HARM REDUCTION; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; PUBLIC HEALTH; PUBLIC RELATIONS; SMOKING; SOCIAL BEHAVIOR; TOBACCO; TOBACCO INDUSTRY;

COMMUNICATION; DOCUMENTATION; HARM REDUCTION; HEALTH POLICY; HUMANS; PUBLIC HEALTH; PUBLIC RELATIONS; SMOKING; SOCIAL RESPONSIBILITY; TOBACCO; TOBACCO INDUSTRY;

EID: 84923263746     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2013-051502     Document Type: Article

References (107)

1. Philip M. Speech by David Davies Philip Morris Senior Vice President Corporate Affairs, at the National Press Club Canberra 23 March 2005. 2005 [cited 2012 11 June]. http://tobacco.health.usyd.edu.au/assets/pdfs/harm-reduction/DDaviesHR-2005.pdf
2. British American Tobacco. Research & Development at British American Tobacco. Undated [cited 2013 4 March]. http://www.bat-science.com/
3. Williamson J, Proctor C. Should the health community promote smokeless tobacco (Snus): comments from British American Tobacco. PLoS Medicine 2007;4.
4. Patwardhan S. Correspondence: the potential role of snus products within a tobacco harm reduction strategy. J Pub Health Adv Access 2009;31:310–11.
5. Gartner CE, Hall WD, Chapman S, et al. Should the health community promote smokeless tobacco (Snus) as a harm reduction measure? PLoS Medicine 2007;4:1138–41.
6. Gilmore AB, Peeters S. Rapid response to Martin McKee’s ‘E-cigarettes and the marketing push that suprised everyone’. BMJ 2013;347(f5780).
7. Henningfield JE, Fagerstrom KO. Swedish match company, Swedish snus and public health: a harm reduction experiment in progress? Tobacco Control 2001;10:253–7.
8. Fagerstrom KO, Schildt E-B. Should the European union lift the ban on snus? Evidence from the Swedish experience. Addiction 2003;98:1191–5.
9. Foulds J, Ramstrom L, Burke M, et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 2003;12:349–59.
10. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can’t quit. A report by the Tobacco Advisory Goup of the Royal College of Physicians. RCP, ed. London: RCP, 2007.
11. Gartner CE, Hall WD, Vos T, et al. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet (British edition) 2007;369:2010–14.
12. Parascandola M. Tobacco harm reduction and the evolution of nicotine dependence. Am J Public Health 2011;101:632–41.
13. Chapman S. Public Health Advocacy and Tobacco Control. Making Smoking History. Wiley-Blackwell, 2007.
14. European Commission. Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products. Official J Eur Communities 2001 (L94):26-35.
15. Aguinaga Bialous S, Peeters S. A brief overview of the tobacco industry in the last 20 years. Tob Control 2012;21:92–4.
16. Peeters S, Gilmore AB. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials. PLOS Medicine 2013;10.
17. Stotesbury S. Smokeless tobacco: EU dogma or dialogue? in EurActiv.com, 2012.
18. European Commission Health and Consumers Directorate-General. Report on the public consultation on the possible revision of the Tobacco Products Directive (2001/37/EC). Brussels, 2011.
19. Philip Morris International. Philip Morris International’s input to the public consultation on the possible revision of the Tobacco Products Directive 2001/37/ EC. 2010 [cited 2011 16 December 2011]. http://www.pmi.com/eng/tobacco_regulation/submissions/documents/PMI_Input_to_public_consultation_on_tobacco_products_directive_with%20annexes_15_Dec_2010.pdf
20. Burritt C. Swedish Match Targets Wall Street Smokers with Snus Tobacco, in Bloomberg online news, 2010.
21. Meija AB, Ling PM. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health 2010;100:78–87.
22. Tomar SL, Alpert HR, Connolly GN. Patterns of dual use of cigarettes and smokeless tobacco among U.S. males: findings from national surveys. Tob Control 2010;19:104–9.
23. Tomar SL. Snuff use and smoking in U.S. men implications for harm reduction. Am J Prev Med 2002;23:143–9.
24. Hurt RD, Ebbert JO, Muggli ME, et al. Open doorway to truth: legacy of the Minnesota Tobacco Trial. Mayo Clin Proc 2009;84:446–56.
25. Forster N. The Analysis of Company Documentation. In: Cassell C, Symon G eds. Qualitative Methods in Organizational Research: A Practical Guide. Sage Publications, 1997, chapter 9.
26. Hill MR. Archival Strategies and Techniques, in Qualitative Research Methods Volume 31. Sage Publications, 1993.
27. Ritchie J, Spencer L. Qualitative Data Analysis in Applied Policy Research. In: Huberman A, Miles M eds. The Qualitative Researcher’s Companion. Sage Publications Inc., 2002, 305–30.
28. Patskan G. Harm Reduction Overview, 2003. Bates no: 3034174263- 3034174266. http://legacy.library.ucsf.edu/tid/vtu94g00
29. Patskan G. Wsa 20020000 Proposed Project Plan. Harm Reduction Guidelines, 2001. Bates no: 3012512047. http://legacy.library.ucsf.edu/tid/aus94g00
30. Bates no: 2505230949/0950. http://legacy.library.ucsf.edu/tid/cgt39c00
31. Patskan G. Worldwide Scientific Affairs 20020000 Planned Project N01383. Harm Reduction Guidelines, 2002. Bates no: 3012511764-3012511765. http://legacy.library.ucsf.edu/tid/qmf91g00
32. Future Business Environment 2000. Bates no: 321519460–321519525, 2000. http://legacy.library.ucsf.edu/tid/ylk93a99
33. Future Business Environment 2001. Bates no: 324537933–324538045, 2001. http://legacy.library.ucsf.edu/tid/qal55a99
34. Berlind M. R582, 1999. Bates no: 2074406493A. http://legacy.library.ucsf.edu/tid/ ibr17d00
35. Stratton K, et al. ed. Institute of Medicine, Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, Washington, DC: National Academy Press, 2001.
36. Stratton K. Letter from Kathleen Stratton to Rufus H Honeycutt regarding harmful substances in tobacco, 2000. Bates no: 325313912-325313915. http://legacy.library.ucsf.edu/tid/jvy92a99
37. McAdam K. Meeting with IONM, 2000. Bates no: 325193568-325193576. http://legacy.library.ucsf.edu/tid/zzr72a99
38. Stratton K. 2000. Bates no: 2505230943/0948. http://legacy.library.ucsf.edu/tid/bgt39c00
39. Marshall A. [Transcript of Adrian Marshall]. Bates no: 325050319-325050340. http://legacy.library.ucsf.edu/tid/pap14a99
40. Massey E. Preliminary Consideration on the IOM Letter of April 17, 2000, 2000. Bates no: 325291814-325291816. http://legacy.library.ucsf.edu/tid/zgf71a99
41. Carchman RA. Harm Reduction Memo, 2000. Bates no: 2081499415/9417. http://legacy.library.ucsf.edu/tid/rbg47c00
42. Briefing Hong Kong, 2000. Bates no: 2082674020/4043. http://legacy.library.ucsf.edu/tid/jct55c00
43. Inbifo. Cologne Visit from Representatives of the Uk Doh 20011112 Agenda, 2001. Bates no: 2085795539. http://legacy.library.ucsf.edu/tid/cdx94c00
44. Carchman RA. Notes of the Philip Morris USA Scientific Advisory Board Meeting, 20011107 & 20011108, 2001. Bates no: 2085523897/3899. http://legacy.library.ucsf.edu/tid/wcs10c00
45. Patskan G. Harm Reduction Overview: Review of Iom Regulatory Principles and Philip Morris’s Approach. Sab Meeting 20020312-20020313, 2002. Bates no: 3001346970-3001346998. http://legacy.library.ucsf.edu/tid/byg96g00
46. Carchman RA. Notes of the Philip Morris USA Scientific Advisory Board Meeting, 20020312-20020313, 2002. Bates no: 2505914404/4407. http://legacy.library.ucsf.edu/tid/kyn81c00
47. Gov’t Reform Statement Summary. Doc, 2003. Bates no: 5001007419/ 5001007422. http://legacy.library.ucsf.edu/tid/wfa17a00
48. 2005-04-28 Meeting with AGs from several states, Lund to NAAG (Presentation) Confidential.ppt^PowerPointPresentation.ppt, 2005. Bates no: 3116034898/ 3116034905. http://legacy.library.ucsf.edu/tid/ndb82i00
49. “Communication of information resulting from the monitoring of a reduced risk cigarette product”, 1997. Bates no: 2505220705/0711. http://legacy.library.ucsf. edu/tid/nmw39c00
50. R&D Strategic Overview, 1997. Bates no: 2076927142/7159. http://legacy.library.ucsf.edu/tid/naf85c00.
51. Research Rationale Objectives. Bates no: 102236502-102236504. http://legacy.library.ucsf.edu/tid/nkd66a99
52. BAT Group R&D Programme 1986: Group Projects, 1985. Bates no: 107348380– 107348525. http://legacy.library.ucsf.edu/tid/obs66a99
53. Reduction of “Other Noxae”. Bates no: 400010843-400010848. http://legacy.library.ucsf.edu/tid/qhz42a99
54. Physicians for a Smoke-free Canada. The history of the Canadian safer cigarette program. Ottawa: Physicians for a Smoke-Free Canada, 2002.
55. Givel M. In search of the less hazardous cigarette. Int J Health Serv 2011;41:77–94.
56. Proctor C. Sometimes a cigarette is just a cigarette. London: Sinclair-Stevenson, 2003.
57. British American Tobacco. Full Social Report 2001/02. 2002 [cited 2011 9 December]. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO6RZGHL?opendocument&SKN=1
58. Walker R. Proposal for the Development of a Harm Reduction Strategy (HRS), 2000. Bates no: 325295231-325295237. http://legacy.library.ucsf.edu/tid/ijl24a99
59. Risk Assessment Meeting. Bates no: 325161807-325161808. http://legacy.library.ucsf.edu/tid/onx70a99
60. McAughey J. Risk Assessment Forum—First Meeting, 2000. Bates no: 325295213-325295214. http://legacy.library.ucsf.edu/tid/gln33a99
61. Fisher A-L. Risk Assessment Meeting—30th November 2000, 2000. Bates no: 325381957-325381958. http://legacy.library.ucsf.edu/tid/bsy61a99
62. Possible Invites to Round—Table Discussion of ‘Tobacco Harm Reduction’ Assessment Criteria. Bates no: 325295244-325295246. http://legacy.library.ucsf.edu/tid/ojl24a99
63. Gregg EO. Risk Assessment Meeting, 2000. Bates no: 325161791-325161793. http://legacy.library.ucsf.edu/tid/jnx70a99
64. Sullivan F. Meeting on 30th November, 2000. Bates no: 325161789-325161790. http://legacy.library.ucsf.edu/tid/inx70a99
65. Scientific Research Group Meeting, 2000. Bates no: 325294841-325294847. http://legacy.library.ucsf.edu/tid/ehl24a99
66. Fisher A-L. Risk Assessment Meeting 30th November 2000, 2000. Bates no: 325161806. http://legacy.library.ucsf.edu/tid/nnx70a99
67. Fisher A-L. Risk Assessment Meeting—30th Nov, 2000. Bates no: 325381953- 325381954. http://legacy.library.ucsf.edu/tid/zry61a99
68. Gregg E. Meeting on 30 November, 2000. Bates no: 325381959. http://legacy.library.ucsf.edu/tid/csy61a99
69. Operational Planning Meeting 11th April 2001—Minutes, 2001. Bates no: 325106298-325106300. http://legacy.library.ucsf.edu/tid/ebs62a99
70. British American Tobacco. Full Social Report, 2005. [cited 2013 18 February]. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO6RZGHL?opendocument&SKN=1
71. Euromonitor International, Euromonitor Tobacco Passport: Sweden snus 2001– 2009, by Global Brand Owner, Retail Volume, % breakdown. 2010.
72. Euromonitor International, Euromonitor Tobacco Passport: Norway snus, 2006– 2009, by Global Brand Owner, Retail Volume, % breakdown. 2010.
73. British American Tobacco. Smokeless tobacco and health. 2012 [cited 2012 17 December]. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO6CPCXZ?opendocument&SKN=1
74. Philip Morris International. Health Effects of Snus. 2012 [cited 2012 17 December]. http://www.pmi.com/eng/our_products/snus/pages/health_effects_of_snus.aspx
75. Philip Morris International, 2008 Annual Report. 2009.
76. British American Tobacco. Harm reduction: Engagement. Undated [cited 2013 18 March]; http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO52AMGZ?opendocument&SKN=1
77. Japan Tobacco International. How we do business: Reduced-risk products. 2012 26 March 2012 [cited 2013 18 March 2013]; http://www.jti.com/how-we-dobusiness/smoking-and-health/reduced-risk-products/
78. Imperial Tobacco. Tobacco products: Potentially Reduced Exposure Products (PREPs). 2013 [cited 2013 18 March]; http://www.imperial-tobacco.co.uk/index.asp?page=493
79. British American Tobacco. Sustainability Report 2011. 2012: London.
80. British American Tobacco, Annual Review and Summary Financial Statement 2005. London, 2006:12.
81. British American Tobacco, Annual Report and Accounts 2007. London, 2008:25.
82. Payne A. Meeting with Mohammed Haroon: DOH, 2000. Bates no: 325124869- 325124870. http://legacy.library.ucsf.edu/tid/fkc53a99
83. Bates no: 2081500255/0258. http://legacy.library.ucsf.edu/tid/klo65c00
84. Davies D. Further Meeting, 2000. Bates no: 2081500459D/0460. http://legacy.library.ucsf.edu/tid/xmo65c00
85. ZXCHERYL.SWANN@DOH.GSI.GOV.UK, RE: FURTHER MEETING, 2000. Bates no: 2081500459C. http://legacy.library.ucsf.edu/tid/wmo65c00
86. Davies D. Re: Further meeting, 2000. Bates no: 2081500459B. http://legacy.library.ucsf.edu/tid/vmo65c00
87. Diethelm PA, Rielle J-C, McKee M. The whole truth and nothing but the truth? The research that Philip Morris did not want you to see. Lancet 366:86–92.
88. Dempsey R. Re: Inbifo Follow-Up, 2001. Bates no: 2505954990. http://legacy.library.ucsf.edu/tid/sah77c00
89. Sanders E. Dawn Milner Visit, 2001. Bates no: 2085798956A. http://legacy.library.ucsf.edu/tid/ndw51h00
90. Sanders E. Re: Visit to Inbifo, 2001. Bates no: 2505940991. http://legacy.library.ucsf.edu/tid/lim43a00
91. ZXMARILYNE.DUVIGNEAU@DOH.GSI.GOV.UK, Visit to Inbifo, 2001. Bates no: 2505940992/0993. http://legacy.library.ucsf.edu/tid/kim43a00
92. Sanders E, Xx TED. Fw: Visit to Inbifo, 2001. Bates no: 2505940990. http://legacy.library.ucsf.edu/tid/mim43a00
93. Fooks GJ, Gilmore AB, Smith KE, et al. Corporate social responsibility and access to policy Élites: an analysis of tobacco industry documents. PLoS Med 2011;8: e1001076.
94. British American Tobacco. Stakeholder engagement. undated [cited 2013 4 February]. http://www.bat.com/groupfs/sites/BAT_8NXDKN.nsf/vwPagesWebLive/DO8QDMEK?opendocument&SKN=1
95. Hirschhorn N. Corporate social responsibility and the tobacco industry: hope or hype? Tob Control 2004;13:447–53.
96. Fooks GJ, Gilmore A, Collin J, et al. The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR. J Bus Ethics 2013;112:283–99.
97. Tobacco Advertising and Sponsorship. The Next Three Years: Conference Report, 1986. Bates no: 107349911-107349918. http://legacy.library.ucsf.edu/tid/sej66a99
98. Nicoventures. Our team: Adrian Marshall. Undated [cited 2013 19 March]; http://www.nicoventures.co.uk/our-team/
99. The CORA Roadmap; CORA Regional Meetings—June 2000, 2000. Bates no: 325419015-325419028. http://legacy.library.ucsf.edu/tid/xzz24a99
100. Statement of CR Principles, 2001. Bates no: 2712701389/2712701391. http://legacy.library.ucsf.edu/tid/bgm72i00
101. PM USA corporate responsibility: internal footprint exploration—interview, 2002. Bates no: 2067193034/2067193120.001. http://legacy.library.ucsf.edu/tid/ orn29h00
102. British American Tobacco. Thank you for visiting! [Archived webpage dated 11 May 2000]. 2000 [cited 2012 10 October]. http://web.archive.org/web/20000510214408/http://www.bat.com/bat/homepage.nsf/fsHPG_mainfs!OpenFrameSet
103. British American Tobacco. Sustainability Report 2010. 2011 [cited 2011 23 August 2011]. http://www.bat.com/groupfs/sites/BAT_89HK76.nsf/vwPagesWebLive/DO7QJMQZ?opendocument&SKN=1
104. Heath A. Smokeless Tobacco, 1984. Bates no: 301551981-301551985. http://legacy.library.ucsf.edu/tid/qtf18a99
105. World Health Organization. WHO Framework Convention on Tobacco Control. Geneva, 2003.
106. British American Tobacco. Annual Report 2011. London, 2012.
107. Food and Drug Administration. Industry Representative Pool Risk Communication Advisory Committee. 2010. [cited 2011 29 March]. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/RiskCommunicationAdvisoryCommittee/UCM199769.pdf